E31 Polyglandular dysfunction
E31 is the ICD-10-CM code family for Polyglandular dysfunction: 8 codes, all of which can lead a home health claim.
Codes in family
8
Can lead a claim
8
Cannot lead a claim
0
What CMS assigns to E31
All 8 codes group to MMTA - Endocrine (5) and MMTA - Other (3). None of the 8 is assigned a comorbidity subgroup. Every code can lead a claim.
Every code in E31
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| E31.0 | Autoimmune polyglandular failure | Can lead a claim | I | None |
| E31.1 | Polyglandular hyperfunction | Can lead a claim | A | None |
| E31.2 Multiple endocrine neoplasia [MEN] syndromes | ||||
| E31.20 | Multiple endocrine neoplasia [MEN] syndrome, unspecified | Can lead a claim | I | None |
| E31.21 | Multiple endocrine neoplasia [MEN] type I | Can lead a claim | I | None |
| E31.22 | Multiple endocrine neoplasia [MEN] type IIA | Can lead a claim | I | None |
| E31.23 | Multiple endocrine neoplasia [MEN] type IIB | Can lead a claim | A | None |
| E31.8 | Other polyglandular dysfunction | Can lead a claim | A | None |
| E31.9 | Polyglandular dysfunction, unspecified | Can lead a claim | I | None |
Sources: CMS HH PPS Grouper Software (opens in a new tab) v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 (opens in a new tab) code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.